Last A$0.03 AUD
Change Today +0.012 / 92.31%
Volume 105.0M
GTG On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ CM
Frankfurt
As of 12:10 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mervyn Cass MBBS

Former Non-Executive Director, Chairman of Corporate Governance Committee and Member of Audit Committee, Genetic Technologies Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

73A$58,585

Background*

Dr. Mervyn Cass, MBBS served as the Founding Chairman of the Australasian Occupational Medical Group. Dr. Cass is a Practising Medical Practitioner and, after 28 years as the Senior Partner in an occupational medical practice in Port Melbourne, has been Medical Director of a plastic surgery centre since 1996. Dr. Cass served as a Non-Executive Director of Genetic Technologies Limited since September 30, 2011. He served as a Director of Wolfe Research Pty. Ltd. He has ...

Read Full Background

Corporate Headquarters*

60-66 Hanover Street
Fitzroy, Victoria 3065

Australia

Phone: 61 3 8412 7000
Fax: 61 3 8412 7040

Board Members Memberships*

2011-N/A
Former Non-Executive Director, Chairman of Corporate Governance Committee and Member of Audit Committee

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash CompensationA$58,585
Total Calculated CompensationA$58,585
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTG:AU A$0.03 AUD +0.012

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William P. Sullivan Chief Executive Officer, Executive Director and Member of Executive Committee
Agilent Technologies Inc.
$1.0M
Colin Stephen Goldschmidt M.B., B.Ch., F.R.C.P.A., F.A.I.C.D.Chief Executive Officer, Managing Director, Executive Director, Member of Risk Management Committee and Chief Executive Officer of Douglass Hanly Moir Pathology
Sonic Healthcare Limited
A$3.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENETIC TECHNOLOGIES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.